NCT05735366
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05735366
Title A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Chugai Pharmaceutical
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
Georgia Cancer Center at Augusta University Augusta Georgia 30912 United States Details
MUSC Hollings Cancer Center Charleston South Carolina 29425 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
National Cancer Center Hospital East Kashiwa Chiba 277-8577 Japan Details
National Cancer Center Hospital Tokyo Chuo Ku 104-0045 Japan Details
Cancer Institute Hospital of JFCR Tokyo Koto Ku 135-8550 Japan Details
Shizuoka Cancer Center Shizuoka Sunto-gun 411-8777 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field